TNF and dermatomyositis: Some case reports and case series show beneficial effects [59, 60], while others report no efficacy or even exacerbation of disease after treatment with the TNF-α inhibitor infliximab (a monoclonal antibody) or etanercept (a recombinant fusion protein) [61, 62] in patients with PM and DM.